Association between factor v leiden gene mutation and systemic involvement in behcet's disease;Behçet hastaliǧinda sistemik tutulum ve faktör v leiden gen mutasyonu arasindaki Ilişki

Turkderm Deri Hastaliklari ve Frengi Arsivi

Volumn 43, Issue 1, 2009, Pages 21-24

  Cebeci, Filiz ^a   Topçu, Elif ^a   Onsun, Nahide ^a   Su, Özlem ^a  

^a Dermatoloji ve Veneroloji Kliniǧi ^*  (Turkey)

Author keywords

Behcet's disease and factor v leiden gene mutation

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN;

ADULT; APHTHOUS ULCER; ARTICLE; BEHCET DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GENITAL ULCER; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; SKIN DEFECT; STATISTICAL ANALYSIS; SYSTEMIC DISEASE; THROMBOSIS; UVEITIS;

EID: 63049134640     PISSN: 1019214X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Behçet H: Über rezidivierende aphthouse durch ein virus verursachte Geschwuere am Mund, am Auge und an den Genitalien. Dermatol Monatsschr Wochenschr 105: 1152-7.
2. Sakane T, Takeno M, Suzuki N et al: Behçet's disease. N Engl J Med 1999;341:1284-91.
3. Koç Y, Gullu I, Akpek G et al: Vasculer involvement in Behçet's disease. J Rheumatol 1992;19:402-10.
4. Gul A, Ozbek U, Ozturk C et al: Coagulation factor V gene mutation increases the risk of venous thrombosis in Behçet's disease. Br J Rheumatol 1996;35:1178-80.
5. Mammo L, Daalan A, Bahabri S et al: Association of factor V leiden with Behçet's disease. J Rheumatol 1997;24:2196-8.
6. Verity DH, Vaughan R, Madanat W et al: Factor V leiden mutation is associated with ocular involvement in Behcet disease. Am J Ophthalmol. 1999;128:352-6.
7. Svensson PJ, Dhalback B: Resistance to activated prothein C as a basis for venous thrombosis. N Engl J Med 1994;330:517-22.
8. Rosendaal FR, Koster T, Vandenbroucke JP et al: High risk of thrombosis in patients homozygous for factor V Leiden (activated protein C resistance). Blood 1995;85:1504-8.
9. Akar N, Akar E, Dalg?n G et al: Frequency of factor V (1691G-A) mutation in Turkish population. Thromb Haemost 1997;78:1527-8.
10. Vurkun M, Vural Ö, Demir M et al: The prevalenve of activated protein C resistence ans F V Liden in healthy population of Edirne. Turk J Haematol 2002:19;287-91.
11. International Study Group for Behçet's disease. Evaluation of diagnostic ('Classification') criteria in Behçet's disease-towards internationally agreed criteria. Br J Rheumatol 1992;31:299-308.
12. Gul A: Behçet's disease: an update on the pathogenesis. Clin Exp Rheumatol 2001;19:6-12.
13. Fietta P: Behçet's disease: familial clustering and immunogenetics. Clin Exp Rheumatol. 2005;238:96-105.
14. Oner AF, Gurgey A, Gurler A et al: Factor V leiden mutation in patients with Behçet's disease. J Rheumatol 1998;25:496-8.
15. Batioglu F, Atmaca LS, Karabulut HG et al: Factor V leiden and prothtombin gene G20210A mutations in ocular Behçet disease. Acta Ophtalmol Scand 2003:81;283-5.
16. Leiba M, Sidi Y, Gur H et al: Behçet's disease and thrombophilia. Ann Rheum Dis 2001;60:1081-5.
17. Haznedaroglu IC, Ozcebe OI, Ozdemir O et al: Impaired haemostatic kinetics and endothelial function in Behçet's disease. J Intern Med 1996;240:181-7.
18. Gurgey A, Balta G, Boyvat A: Factor V leiden mutation and PAI-1 gene 4G/5G genotype in thrombotic patients with Behçet's disease. Blood Coagul Fibrinolysis. 2003;14:121-4.
19. Toydemir PB, Elhan AH, Tutkun A et al: Effects of factor V gene G1691A, methylenetetrahydrofolate reductase gene C677T, and prothombin gene G20210A mutations on deep venous thrombogenesis in Behçet's disease. J Rheumatol 2000;27:2849-54.
20. Leiba M, Seligsohn U, Sidi Y et al: Thrombophilic factors are not the leading cause of thrombosis in Behçet's disease. Ann Rheum Dis 2004;63:1445-9.
21. Ates A, Duzgun N, Ulu A et al: Factor V gene (1691A and 4070G) and prothrombin gene 20210A mutations in patients with Behçet's disease. Pathophysiol Haemost Thromb 2003;33:157-63.
22. Espinosa G, Font J, Tassies D et al: Vascular involvement in Behçet's disease: relation with thrombophilic factors, coagulation activation, and thrombomodulin. Am J Med 2002;112:37-43.
23. Silingardi M, Salvarani C, Boiardi L et al: Factor V Leiden and prothrombin gene G20210A mutations in Italian patients with Behçet's disease and deep vein thrombosis. Arthritis Rheum 2004;15:177-83.
24. Soy M, Tanriverdi K, Kocak R et al: Factor V leiden mutation in Behçet's disease. Ann Med Sci 2000;9:22-3.
25. Chen Y, Stanford MR, Wallace GR et al: Factor V Leiden mutation does not correlatewith retinalvascularocclusionin whitepatients with Behçet's disease. Br J Ophthalmol 2003;87:1048-9.
26. Tursen U, Kaya TI, Eskandari G et al: Association of factor V leiden and prothrombin gene mutation with Behçet's disease. Arch Dermatol Res 2001;293:537-9.
27. Koşar A, Öztürk M, Haznedaroǧlu CI: Hemostatic parameters in Behçet's disease: a reappraisal. Rheumatol Int 2002;22:9-15.